not tagged
not tagged
morie gertz highlighting how therapeutic mm trial design inherently disadvantages frail older adults in mm, we need dedicated trials incorporating frailty in design #ims2022
Multiple Myeloma Lead, Juravinski Cancer Centre
Clinical Investigator
Assistant Professor, McMaster University